Regeneron Pharmaceuticals
REGN
#230
Rank
S$126.57 B
Marketcap
S$1,224
Share price
-0.93%
Change (1 day)
33.34%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): S$7.30 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are S$16.89 Billion. In 2025 the company made an earning of S$6.74 Billion, an increase over its 2024 earnings that were of S$6.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$7.30 B8.28%
2025 S$6.74 B9.43%
2024 S$6.16 B13.83%
2023 S$5.41 B-13.57%
2022 S$6.26 B-47.9%
2021 S$12.02 B144.75%
2020 S$4.91 B56.86%
2019 S$3.13 B-4.87%
2018 S$3.29 B22.86%
2017 S$2.68 B56.3%
2016 S$1.71 B8.55%
2015 S$1.57 B54.53%
2014 S$1.02 B11.14%
2013 S$0.91 B72.13%
2012 S$0.53 B-285.93%
2011 -S$0.29 Billion121.73%
2010 -S$0.13 Billion37.18%
2009 -S$94.5 Million-14.6%
2008 -S$0.12 Billion-25.02%
2007 -S$0.15 Billion6.32%
2006 -S$0.14 Billion-186.52%
2005 S$0.16 B2103.7%
2004 S$7.28 M-105.66%
2003 -S$0.13 Billion-18.18%
2002 -S$0.16 Billion42.33%
2001 -S$0.12 Billion129.35%
2000 -S$48.18 Million51.87%
1999 -S$31.73 Million92.19%
1998 -S$16.51 Million66.23%
1997 -S$9.93 Million-55.49%
1996 -S$22.31 Million103.53%
1995 -S$10.97 Million-70.89%
1994 -S$37.66 Million-26.08%
1993 -S$50.94 Million114.67%
1992 -S$23.73 Million196.77%
1991 -S$8 Million87.88%
1990 -S$4.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.14 B 229.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.30 B 122.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$14.25 B 94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$10.04 B 36.95%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$0.57 B-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.57 B-78.52%๐Ÿ‡บ๐Ÿ‡ธ USA